How to have your cake and eat it too: Differences in commercializing clinical and consumer products

There is a turmoil in health and wellness world. As governments and health insurers worldwide implement measures to control costs, public hospitals are operating on tighter budgets, while private facilities are receiving lower reimbursements. These measures are triggering a transformation of the ...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

Emerging go-to-market strategies overcome regulatory and reimbursement hurdles to tap into the $4 trillion health and wellness market

Analyst Insight | December 02, 2020

Currently, the most common approach to a new healthcare solution is building it with a particular set of insurance reimbursement codes in mind (see this insight), getting clinical validation as part of the regulatory approval process, and deploying to the market with a reimbursement plan already in ... Not part of subscription

The two key issues of cognitive nutrition startup TruBrain are common to many functional nutrition developers

News Commentary | May 17, 2021

TruBrain announced a crowdfunding campaign to serve consumers for personalized health. With neuroscience expertise and patent‑pending formulas, TruBrain claims its personalized products can improve users' cognition. However, the claim is questionable due to two issues applicable to many functional ... Not part of subscription

Cognoa prepares the ground with initial FDA approval for multipronged market approach

News Commentary | June 16, 2021

This is an important development not only from the care perspective – as early identification of autism is critical to helping children yet is often stymied by lack of access – but from a market perspective. Cognoa is building an ecosystem for autism that considers the patient journey. By starting ... To read more, click here.